These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 26095102)
1. Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients With Non-Small Cell Lung Cancer. Cui J; Tian H; Chen G Ann Thorac Surg; 2015 Aug; 100(2):465-72. PubMed ID: 26095102 [TBL] [Abstract][Full Text] [Related]
2. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Li SH; Tian H; Yue WM; Li L; Li WJ; Chen ZT; Hu WS; Zhu YC; Qi L Ann Surg Oncol; 2011 Jul; 18(7):2048-56. PubMed ID: 21290196 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Takanami I Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511 [TBL] [Abstract][Full Text] [Related]
5. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC. Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer. Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841 [TBL] [Abstract][Full Text] [Related]
7. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer. Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372 [TBL] [Abstract][Full Text] [Related]
8. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438 [TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746 [TBL] [Abstract][Full Text] [Related]
10. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances]. Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Yuan A; Yang PC; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228 [TBL] [Abstract][Full Text] [Related]
14. [Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density]. Han ZG; Yu TT; Shan L Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):605-8. PubMed ID: 23158995 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry. Bing Z; Jian-ru Y; Yao-quan J; Shi-feng C Cell Biochem Biophys; 2014 Sep; 70(1):327-31. PubMed ID: 24676677 [TBL] [Abstract][Full Text] [Related]
17. Astrocyte elevated gene-1 is overexpressed in non-small-cell lung cancer and associated with increased tumour angiogenesis. Ding Q; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Ma Z Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):395-401. PubMed ID: 29049797 [TBL] [Abstract][Full Text] [Related]
18. The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma. Dundar E; Oner U; Peker BC; Metintas M; Isiksoy S; Ak G J Int Med Res; 2008; 36(1):88-95. PubMed ID: 18230272 [TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676 [TBL] [Abstract][Full Text] [Related]
20. Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer. Tanaka F; Oyanagi H; Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H Cancer Res; 2003 Oct; 63(20):6791-4. PubMed ID: 14583475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]